FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/10/2024
Back to search
Official data from USPTO
EVLABIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EVLABIO
ST13
US500000079351651Class
5, 9, 35, 36, 42
Filing
79351651
Registration
7497680
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
12/10/2024
Trademark type
Word
Nice classes
5, 9, 35, 36, 42
Filing date
05/23/2022
Registration date
09/10/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/10/2024
Last transaction
11/21/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH-8038 Zürich, CH
Examiner
THOMAS, JULIE
Law office
L70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
EvlaBio AG
D. K. (pessoa física)
Representatives
Pamela N. Hirschman Davis Graham & Stubbs LLP
Technical classification
Nice Classes
Class 5Class 9Class 35Class 36Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for human usepreparations for the prevention and treatment of cancer and kidney diseases or disorderspreparations for the prevention and treatment of metabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryoncologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorderspreparations for the prevention and treatment of infectious diseasesblood disorderspaininflammationsepsiscognitive disordersdiabetes; biologic preparations for medical and therapeutic purposespreparations for the prevention and treatment of cancer and kidney diseases or disorderspreparations for the prevention and treatment of metabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryoncologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorderspreparations for the prevention and treatment of infectious diseasesblood disorderspaininflammationsepsiscognitive disordersdiabetes
Class 9
Data processing equipmentcomputer hardware; downloadable and recorded computer software for providinganalyzing and generating reports in the field of healthcarepharmaceutical and biomedical research; downloadable and recorded computer software for data processing in the field of healthcarepharmaceutical and biomedical research; electronic data processing apparatusdownloadable and recorded softwarecomputer programs and hardware for the scientific analysis and electronic storage of artificial intelligence data in the field of healthcarepharmaceutical and biomedical research; all of the aforementioned goods in the field of healthcarepharmaceutical and biomedical research; downloadable and recorded software for scientific analysis of clinical trial data in the fields of public healthhealthcarepharmaceutical and biomedical research and downloadable and recorded software for scientific analysis of data from clinical trials and data derived from post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; downloadable computer software featuring computer databases of pharmaceuticals and medical information; downloadable computer software for management of medical practices and conducting medical research; downloadable computer software for measuringmonitoringprocessing and tracking health and medical information; downloadable computer search engine software for obtaining and providing updated scientificmedicinalpharmaceutical and clinical information; computer hardware and downloadable and recorded software for use with medicinal patient monitoring equipment and for receivingprocessingtransmitting and displaying data in the field of healthcare; downloadable and recorded artificial intelligence software for tracking data for use in medical and scientific healthcare research
Class 35
Business data analysis and statistical analysis for business purposes relating to healthcare databiomedical and pharmaceutical research and clinical trial data and data from post-authorization research for marketing of medicines and commercial post-launching of medicines; business analysis and professional business consultancy services regarding statistics for biomedical researchhealthcare institutions and healthcare professionalsbased on artificial intelligence and machine learning; compilation of business dataanalysis of business data and business management analysis in the field of pharmaceutical and biomedical research and developmentclinical trialspost-authorization research for the marketing of medicines and commercial post-launching of medicinesepidemiological researchpharmaco-epidemiological researchpublic health and healthcare; compilation of business dataanalysis of business data and business management analysis for medicalpublic health and healthcare purposes; business researchbusiness market research and statistical analysis of business data in the fields of public healthhealth carebiomedicine and pharmaceuticalsclinical trials and post-authorization research for the marketing of medicines and commercial post-launching of medicines; providing marketing information regarding market intelligence services and competitive intelligence services in the fields of pharmaceuticalsbiomedicineclinical trialspost-authorization research for the marketing of medicines and commercial post-launching of medicinesepidemiological researchpharmaco-epidemiological researchpublic health and healthcare; business risk management and business risk assessment services in the fields of pharmaceuticals and biomedicine; business services provided to the healthcare industrythe collectionbusiness reportinganalysis of healthcare data for business purposes
Class 36
Financial analysis of investments in pharmaceutical and biomedical research and development and clinical trials and post-authorization research; providing financial services with respect to securities and other financial instruments and productstrading of and investments in securities and financial instruments and products for others; financial evaluationtrackinganalysisforecastingconsultancy and research services relating to securities and other financial instruments; financial research related to financial instruments; clearing and reconciling financial transactions via blockchain technology; electronic funds transfer provided via blockchain technology
Class 42
Product research in the field of medicalpharmaceutical and biologic therapeutic products; medical researchpharmaceutical research and pharmaceutical drug development services; providing scientific research information in the field of medicalpharmaceuticalsbiomedicineclinical trials and post-authorization research and commercial post-launching of medicines; providing temporary use of online non-downloadable computer software containing databases of pharmaceutical productsmedical informationclinical trial data and data derived from post-authorization research for the marketing of medicines and commercial post-launching of medicines; providing temporary use of online non-downloadable computer software for management of medical practices and conducting medical research; providing temporary use of online non-downloadable computer search engine software for obtaining and providing updated scientificmedical and clinical information; providing temporary use of online non-downloadable computer software for accessing data and information related to healthcare services and patient medicinal information and for controlling and managing data and information related to healthcare services and patient medicinal information; providing temporary use of non-downloadable software applications accessible via a web site for data analyticsfinancial analytics and risk management for use in the fields of pharmaceutical and biomedical research and developmentclinical trialsthe provision of medical and healthcare services; providing temporary use of non-downloadable software for financial analytics via blockchain technology; providing temporary use of non-downloadable artificial intelligence computer programs on data networks for tracking data for use in medical and scientific research; software as a service (SaaS) featuring software platforms for database management in healthcare
Publications
History of USPTO decisions and trademark events.
36 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/17/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/17/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/17/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/10/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
09/10/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
08/01/2024
GPNX
NOTIFICATION PROCESSED BY IB
07/14/2024
CHLD
CHANGE OF OWNER RECEIVED FROM IB
07/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/18/2024
PUBO
PUBLISHED FOR OPPOSITION
06/18/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/11/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/11/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/29/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/13/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/13/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/13/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/13/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/26/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/06/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/06/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/04/2023
GNFR
FINAL REFUSAL E-MAILED
12/04/2023
CNFR
FINAL REFUSAL WRITTEN
12/04/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/30/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/30/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/30/2023
RFNT
REFUSAL PROCESSED BY IB
05/24/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/30/2023
RFRR
REFUSAL PROCESSED BY MPU
04/30/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/12/2023
CNRT
NON-FINAL ACTION WRITTEN
03/11/2023
DOCK
ASSIGNED TO EXAMINER
03/11/2023
MAFR
APPLICATION FILING RECEIPT MAILED
10/11/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/07/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/06/2022
Continuous trademark protection
Get notified about every new filing that threatens EVLABIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.